Back to Search
Start Over
Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research
- Source :
- Global Data Point. October 19, 2023
- Publication Year :
- 2023
-
Abstract
- (GlobeNewswire) - Yield10 Bioscience, Inc. (Nasdaq:YTEN) (Yield10 or the Company), an agricultural bioscience company, today announced that the Company has exercised its option to finalize an exclusive global, commercial license [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Global Data Point
- Publication Type :
- News
- Accession number :
- edsgcl.769473712